Publications

Search for Publications

List of Publications

Sort by: Date | Author | Title

Gögenur, I., Justesen, T. F., Tarpgaard, L. S., Bulut, M., Hansen, T. F., Jensen, L. H., Rahr, H. B., Gögenur, M., Kirkegaard, T., Balsevicius, L., Chieng, M., Raskov, H., Sørensen, M. K. S., Petersen, P. C., Eriksen, J. R., Salomon, S., Fiehn, A.-M. K., Mikkelsen, M. D., Brandsborg, S. ... Qvortrup, C. (2026). Neoadjuvant Single-Cycle Pembrolizumab for Stage I-III MMR-Deficient Colon Cancer: The RESET-C Trial. Journal of Clinical Oncology, 44(18), 1687-1696. https://doi.org/10.1200/JCO-25-02274
Andersen, C. L., Monni, O., Wagner, U., Kononen, J., Barlund, M., Bucher, C., Haas, P., Nocito, A., Bissig, H., Sauter, G. & Kallioniemi, A. (2002). High-throughput copy number analysis of 17q23 in 3520 tissue specimens by fluorescence in situ hybridization to tissue microarrays. American Journal of Pathology, 161(1), 73-79. Article 64158. https://doi.org/10.1016/S0002-9440(10)64158-2
Tarpgaard, L. S., Poulsen, L. Ø., Gögenur, I., Justesen, T. F., Rafaelsen, S. R., Øgaard, N., Demuth, C., Andersen, C. L., Ventzel, L., Larsen, P. Ø., Ramlov, A., Ljungmann, K., Lauritzen, M. B., Diness, L. V., Lykke, J., de Lima, V. A. B., Kjær, S., Salomon, S., Andersen, P. V. & Pfeiffer, P. (2026). Effect of one or two cycles of dual immunotherapy with nivolumab and ipilimumab in patients with mismatch repair-deficient rectal cancer (RESET-R): interim results from a multicentre, single-arm, phase 2 trial. The Lancet Gastroenterology and Hepatology, 11(7), 570-578. https://doi.org/10.1016/S2468-1253(26)00047-6
Box, J. R., Camilo-Contreras, A., Dragoni, F., Yue, F. Y., Matveev, V., Foley, J., Zhang, J., Mok, Y. W., DeSousa, M., Lai, J., Mulcare, Z., Bakewell, Z., Poulin, S., Chano, F., Fortin, C., Tremblay, C., Blankson, J. N., Krishnan, S., Weld, E. D. ... Simonetti, F. R. (2026). 5′ leader defects drive persistent HIV-1 viremia on long-term ART. Nature Communications, 17(1), Article 4725. https://doi.org/10.1038/s41467-026-73475-5